These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15561871)
1. Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. Caronzolo D; Lucini V; Pannacci M; Grosso S; Colleoni F; Fraschini F; Scaglione F Antimicrob Agents Chemother; 2004 Dec; 48(12):4878-81. PubMed ID: 15561871 [TBL] [Abstract][Full Text] [Related]
2. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. Caronzolo D; Lucini V; Pannacci M; Grosso S; Kieffer N; Bello L; Bikfalvi A; Scaglione F Antimicrob Agents Chemother; 2006 Oct; 50(10):3277-82. PubMed ID: 17005805 [TBL] [Abstract][Full Text] [Related]
3. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. Morinaga Y; Yanagihara K; Miyashita N; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Mukae H; Yamada Y; Kohno S; Kamihira S Pulm Pharmacol Ther; 2009 Dec; 22(6):580-6. PubMed ID: 19716898 [TBL] [Abstract][Full Text] [Related]
4. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. Kutlin A; Roblin PM; Hammerschlag MR Antimicrob Agents Chemother; 2002 Feb; 46(2):409-12. PubMed ID: 11796350 [TBL] [Abstract][Full Text] [Related]
5. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. Kohlhoff SA; Roblin PM; Reznik T; Hawser S; Islam K; Hammerschlag MR Antimicrob Agents Chemother; 2004 May; 48(5):1885-6. PubMed ID: 15105151 [TBL] [Abstract][Full Text] [Related]
7. The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials. Yamazaki T; Takemura H; Inoue M; Ogawa M; Ando S; Sato K; Kishimoto T J Chemother; 2008 Aug; 20(4):428-30. PubMed ID: 18676220 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Roblin PM; Reznik T; Kutlin A; Hammerschlag MR Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555 [TBL] [Abstract][Full Text] [Related]
14. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929 [TBL] [Abstract][Full Text] [Related]
15. The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae. Hammerschlag MR; Roblin PM J Antimicrob Chemother; 2004 Jul; 54(1):281-2. PubMed ID: 15190026 [No Abstract] [Full Text] [Related]
17. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology. Kays MB; Lisek CR; Denys GA Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Kutlin A; Roblin PM; Hammerschlag MR Antimicrob Agents Chemother; 1999 Sep; 43(9):2268-72. PubMed ID: 10471577 [TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae enhances Interleukin 8 (IL-8) production with reduced azithromycin sensitivity under hypoxia. Matsuo J; Sakai K; Okubo T; Yamaguchi H APMIS; 2019 Mar; 127(3):131-138. PubMed ID: 30746791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]